News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Joe Stahl, MA

Articles by Joe Stahl, MA

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA

July 2nd 2013

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA

February 12th 2013

Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.

Latest Updated Articles

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Published: February 12th 2013 | Updated:
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Published: July 2nd 2013 | Updated:

Trending on AJMC

CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation

Can a Coffee a Day Keep AFib Away?

5 AI and Digital Health Advances Transforming Breast Cancer Care and Research

2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions

US Spending on High-Revenue Rare Disease Drugs in 2022

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.